Description
The product performs an operation at a privilege level that is higher than the minimum level required, which creates new weaknesses or amplifies the consequences of other weaknesses.
CVE vulnerabilities with CWE-250 (333)
10.0
CVSS
CRITICAL
CVE-2026-4606
pub. 2026-03-23
10.0
CVSS
CRITICAL
CVE-2022-2634
pub. 2022-08-10
10.0
CVSS
CRITICAL
CVE-2022-1517
pub. 2022-06-24
9.9
CVSS
CRITICAL
CVE-2026-48584
pub. 2026-06-19
9.9
CVSS
CRITICAL
CVE-2026-50566
pub. 2026-06-10
9.9
CVSS
CRITICAL
CVE-2026-25212
pub. 2026-04-02
9.9
CVSS
CRITICAL
CVE-2025-32445
pub. 2025-04-15
9.9
CVSS
CRITICAL
CVE-2024-8767
pub. 2024-09-17
9.9
CVSS
CRITICAL
CVE-2024-3330
pub. 2024-06-27
9.8
CVSS
CRITICAL
CVE-2026-34877
pub. 2026-04-02
9.8
CVSS
CRITICAL
CVE-2025-13375
pub. 2026-02-04
9.8
CVSS
CRITICAL
CVE-2025-33223
pub. 2025-12-23
9.8
CVSS
CRITICAL
CVE-2025-33224
pub. 2025-12-23
9.8
CVSS
CRITICAL
CVE-2025-57119
pub. 2025-09-16
9.8
CVSS
CRITICAL
CVE-2024-27143
pub. 2024-06-14
9.8
CVSS
CRITICAL
CVE-2024-25421
pub. 2024-03-26
9.8
CVSS
CRITICAL
CVE-2023-52030
pub. 2024-01-11
9.8
CVSS
CRITICAL
CVE-2023-4662
pub. 2023-09-15
9.8
CVSS
CRITICAL
CVE-2022-44544
pub. 2022-11-06
9.8
CVSS
CRITICAL
CVE-2021-41035
pub. 2021-10-25
Showing 20 of 333 vulnerabilities